APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Irritable Bowel Syndrome Treatment Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Irritable Bowel Syndrome Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174004680321 December 2025193 pages

Choose your research edition.

Industry ResearchIrritable Bowel Syndrome Treatment Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Irritable Bowel Syndrome Treatment Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Irritable Bowel Syndrome Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Irritable Bowel Syndrome Treatment Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Irritable Bowel Syndrome Treatment Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Irritable Bowel Syndrome Treatment Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Irritable Bowel Syndrome Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Irritable Bowel Syndrome Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Irritable Bowel Syndrome Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Irritable Bowel Syndrome Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Irritable Bowel Syndrome Treatment Drug include Takeda Pharmaceutical Ltd, Johnson & Johnson, Roche, Pfizer Inc., Biogen, Abbvie Inc., AstraZeneca, Prometheus Laboratories Inc. (Nestle) and Bristol Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Irritable Bowel Syndrome Treatment Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Irritable Bowel Syndrome Treatment Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Irritable Bowel Syndrome Treatment Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Irritable Bowel Syndrome Treatment Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Irritable Bowel Syndrome Treatment Drug Segment by Company

Takeda Pharmaceutical Ltd

Johnson & Johnson

Roche

Pfizer Inc.

Biogen

Abbvie Inc.

AstraZeneca

Prometheus Laboratories Inc. (Nestle)

Bristol Myers Squibb

Bausch Health

Irritable Bowel Syndrome Treatment Drug Segment by Type

Corticosteroids

Immunomodulators

Antibiotics

Amino Salicylates

Others

Irritable Bowel Syndrome Treatment Drug Segment by Application

Hospitals

Specialty Clinics

Other

Irritable Bowel Syndrome Treatment Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irritable Bowel Syndrome Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Irritable Bowel Syndrome Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irritable Bowel Syndrome Treatment Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Irritable Bowel Syndrome Treatment Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Irritable Bowel Syndrome Treatment Drug industry.

Chapter 3: Detailed analysis of Irritable Bowel Syndrome Treatment Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Irritable Bowel Syndrome Treatment Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Corticosteroids Table 3. Key Players of Immunomodulators Table 4. Key Players of Antibiotics Table 3. Key Players of Amino Salicylates Table 4. Key Players of Others Table 5. Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospitals Table 7. Key Players of Specialty Clinics Table 8. Key Players of Other Table 9. Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region (2021-2026) Table 12. Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region (2027-2032) Table 14. Irritable Bowel Syndrome Treatment Drug Industry Trends Table 15. Irritable Bowel Syndrome Treatment Drug Industry Drivers Table 16. Irritable Bowel Syndrome Treatment Drug Industry Opportunities and Challenges Table 17. Irritable Bowel Syndrome Treatment Drug Industry Restraints Table 18. Global Irritable Bowel Syndrome Treatment Drug Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Company (2021-2026) Table 20. Global Irritable Bowel Syndrome Treatment Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Irritable Bowel Syndrome Treatment Drug Key Company Head Office and Area Served Table 22. Global Irritable Bowel Syndrome Treatment Drug Company, Product Type & Application Table 23. Global Irritable Bowel Syndrome Treatment Drug Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Irritable Bowel Syndrome Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2021-2026) Table 30. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2027-2032) Table 31. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2021-2026) Table 35. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2027-2032) Table 36. Takeda Pharmaceutical Ltd Company Information Table 37. Takeda Pharmaceutical Ltd Business Overview Table 38. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 40. Takeda Pharmaceutical Ltd Recent Development Table 41. Johnson & Johnson Company Information Table 42. Johnson & Johnson Business Overview Table 43. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 45. Johnson & Johnson Recent Development Table 46. Roche Company Information Table 47. Roche Business Overview Table 48. Roche Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Roche Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 50. Roche Recent Development Table 51. Pfizer Inc. Company Information Table 52. Pfizer Inc. Business Overview Table 53. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 55. Pfizer Inc. Recent Development Table 56. Biogen Company Information Table 57. Biogen Business Overview Table 58. Biogen Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Biogen Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 60. Biogen Recent Development Table 61. Abbvie Inc. Company Information Table 62. Abbvie Inc. Business Overview Table 63. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 65. Abbvie Inc. Recent Development Table 66. AstraZeneca Company Information Table 67. AstraZeneca Business Overview Table 68. AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. AstraZeneca Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 70. AstraZeneca Recent Development Table 71. Prometheus Laboratories Inc. (Nestle) Company Information Table 72. Prometheus Laboratories Inc. (Nestle) Business Overview Table 73. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 75. Prometheus Laboratories Inc. (Nestle) Recent Development Table 76. Bristol Myers Squibb Company Information Table 77. Bristol Myers Squibb Business Overview Table 78. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 80. Bristol Myers Squibb Recent Development Table 81. Bausch Health Company Information Table 82. Bausch Health Business Overview Table 83. Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Bausch Health Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 85. Bausch Health Recent Development Table 86. North America Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 87. North America Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 88. North America Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 89. North America Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 90. North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026) Table 92. North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2027-2032) Table 93. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026) Table 99. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2027-2032) Table 100. China Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 101. China Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 102. China Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 103. China Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026) Table 110. Asia Irritable Bowel Syndrome Treatment Drug Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Irritable Bowel Syndrome Treatment Drug Product Image Figure 2. Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Irritable Bowel Syndrome Treatment Drug Market Share by Type: 2025 VS 2032 Figure 4. Corticosteroids Image Figure 5. Immunomodulators Image Figure 6. Antibiotics Image Figure 7. Amino Salicylates Image Figure 8. Others Image Figure 9. Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Irritable Bowel Syndrome Treatment Drug Market Share by Application: 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Specialty Clinics Image Figure 13. Other Image Figure 14. Global Irritable Bowel Syndrome Treatment Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 16. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Irritable Bowel Syndrome Treatment Drug Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Irritable Bowel Syndrome Treatment Drug Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2021-2032) Figure 23. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 26. North America Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032) Figure 27. North America Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032) Figure 28. North America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032) Figure 29. United States Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 30. Canada Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 33. Europe Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032) Figure 34. Europe Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032) Figure 35. Europe Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032) Figure 36. Germany Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 37. France Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 39. Italy Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 40. Russia Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 43. China Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032) Figure 44. China Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032) Figure 45. Asia Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 46. Asia Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032) Figure 47. Asia Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032) Figure 48. Asia Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032) Figure 49. Japan Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 53. India Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 54. Australia Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032) Figure 59. Brazil Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 64. UAE Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 66. Chile Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroids
  • Immunomodulators
  • Antibiotics
  • Amino Salicylates
  • Others
Applications
  • Hospitals
  • Specialty Clinics
  • Other
Companies covered
  • Takeda Pharmaceutical Ltd
  • Johnson & Johnson
  • Roche
  • Pfizer Inc.
  • Biogen
  • Abbvie Inc.
  • AstraZeneca
  • Prometheus Laboratories Inc. (Nestle)
  • Bristol Myers Squibb
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Corticosteroids
  5. 1.2.3 Immunomodulators
  6. 1.2.4 Antibiotics
  7. 1.2.5 Amino Salicylates
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Specialty Clinics
  13. 1.3.4 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Irritable Bowel Syndrome Treatment Drug Growth Trends by Region
  16. 1.5.1 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Irritable Bowel Syndrome Treatment Drug Market Size by Region (2021-2026)
  18. 1.5.3 Irritable Bowel Syndrome Treatment Drug Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Irritable Bowel Syndrome Treatment Drug Market Dynamics
  1. 2.1 Irritable Bowel Syndrome Treatment Drug Industry Trends
  2. 2.2 Irritable Bowel Syndrome Treatment Drug Industry Drivers
  3. 2.3 Irritable Bowel Syndrome Treatment Drug Industry Opportunities and Challenges
  4. 2.4 Irritable Bowel Syndrome Treatment Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Irritable Bowel Syndrome Treatment Drug Revenue by Company (2021-2026)
  2. 3.2 Global Irritable Bowel Syndrome Treatment Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Irritable Bowel Syndrome Treatment Drug Key Company Head office and Area Served
  4. 3.4 Global Irritable Bowel Syndrome Treatment Drug Company, Product Type & Application
  5. 3.5 Global Irritable Bowel Syndrome Treatment Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Irritable Bowel Syndrome Treatment Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Irritable Bowel Syndrome Treatment Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Irritable Bowel Syndrome Treatment Drug Tier 1, Tier 2, and Tier 3
4 Irritable Bowel Syndrome Treatment Drug Market by Type
  1. 4.1 Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2032)
  3. 4.3 Global Irritable Bowel Syndrome Treatment Drug Market Size Share by Type (2021-2032)
5 Irritable Bowel Syndrome Treatment Drug Market by Application
  1. 5.1 Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2032)
  3. 5.3 Global Irritable Bowel Syndrome Treatment Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Ltd
  2. 6.1.1 Takeda Pharmaceutical Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Ltd Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Roche Irritable Bowel Syndrome Treatment Drug Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Pfizer Inc.
  20. 6.4.1 Pfizer Inc. Company Information
  21. 6.4.2 Pfizer Inc. Business Overview
  22. 6.4.3 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Product Portfolio
  24. 6.4.5 Pfizer Inc. Recent Developments
  25. 6.5 Biogen
  26. 6.5.1 Biogen Company Information
  27. 6.5.2 Biogen Business Overview
  28. 6.5.3 Biogen Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Biogen Irritable Bowel Syndrome Treatment Drug Product Portfolio
  30. 6.5.5 Biogen Recent Developments
  31. 6.6 Abbvie Inc.
  32. 6.6.1 Abbvie Inc. Company Information
  33. 6.6.2 Abbvie Inc. Business Overview
  34. 6.6.3 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Product Portfolio
  36. 6.6.5 Abbvie Inc. Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AstraZeneca Irritable Bowel Syndrome Treatment Drug Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Prometheus Laboratories Inc. (Nestle)
  44. 6.8.1 Prometheus Laboratories Inc. (Nestle) Company Information
  45. 6.8.2 Prometheus Laboratories Inc. (Nestle) Business Overview
  46. 6.8.3 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Product Portfolio
  48. 6.8.5 Prometheus Laboratories Inc. (Nestle) Recent Developments
  49. 6.9 Bristol Myers Squibb
  50. 6.9.1 Bristol Myers Squibb Company Information
  51. 6.9.2 Bristol Myers Squibb Business Overview
  52. 6.9.3 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Product Portfolio
  54. 6.9.5 Bristol Myers Squibb Recent Developments
  55. 6.10 Bausch Health
  56. 6.10.1 Bausch Health Company Information
  57. 6.10.2 Bausch Health Business Overview
  58. 6.10.3 Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Bausch Health Irritable Bowel Syndrome Treatment Drug Product Portfolio
  60. 6.10.5 Bausch Health Recent Developments
7 North America
  1. 7.1 North America Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032)
  2. 7.2 North America Irritable Bowel Syndrome Treatment Drug Market Size by Type
  3. 7.2.1 North America Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032)
  6. 7.3 North America Irritable Bowel Syndrome Treatment Drug Market Size by Application
  7. 7.3.1 North America Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032)
  10. 7.4 North America Irritable Bowel Syndrome Treatment Drug Market Size by Country
  11. 7.4.1 North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032)
  2. 8.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Type
  3. 8.2.1 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Application
  7. 8.3.1 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country
  11. 8.4.1 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032)
  2. 9.2 China Irritable Bowel Syndrome Treatment Drug Market Size by Type
  3. 9.2.1 China Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032)
  6. 9.3 China Irritable Bowel Syndrome Treatment Drug Market Size by Application
  7. 9.3.1 China Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032)
  2. 10.2 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Type
  3. 10.2.1 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Application
  7. 10.3.1 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Country
  11. 10.4.1 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Irritable Bowel Syndrome Treatment Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst